Multiple paracrine and immunomodulatory pathways

Multiple paracrine and immunomodulatory pathways refer to the complex, multi-target mechanism of action utilized by advanced therapies, most notably mesenchymal stem cells (MSCs), to influence the host biological environment. Unlike traditional small molecules that inhibit a single enzyme or receptor, this approach relies on the secretion of a broad spectrum of bioactive molecules—including cytokines, chemokines, and extracellular vesicles—that act on neighboring cells to suppress inflammation and promote tissue repair (Galipeau & Sensébé, 2018). These pathways are essential for modulating the activity of various immune cells, such as T-cells, B-cells, and macrophages, shifting them from a pro-inflammatory to an anti-inflammatory phenotype (Pittenger et al., 2019). In clinical settings, these pathways are leveraged to treat complex conditions like graft-versus-host disease (GvHD), Crohn's disease, and acute respiratory distress syndrome (ARDS). Because the term describes a collective biological process rather than a single molecular entity, it is often categorized as a functional mechanism in regenerative medicine (Caplan, 2017). Consequently, therapeutic success is typically monitored through systemic biomarkers of inflammation rather than specific target binding assays.

Other names

Paracrine signalingImmunomodulatory secretomeMSC-mediated immunomodulationParacrine effect

Secretion of a diverse array of bioactive factors, including cytokines, growth factors, and extracellular vesicles, that modulate the local immune environment and stimulate endogenous tissue regeneration.